Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Play-based cognitive behavioral intervention for children with epilepsy

Tests a cognitive behavioral play intervention in children aged 6 to 10 with epilepsy.

Plain-language title generated from the registry record
Registry title: Effect of Cognitive Behavioral Play Intervention and Epilepsy

Key facts

Where
Pavia, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 10 years old?

Source: NCT06813612, who can take part

Where in Italy

  • Child NeuropsichiatryPavia, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
IRCCS National Neurological Institute "C. Mondino" Foundation
Trial code
NCT06813612
Record updated
7 February 2025
Original description
The goal of this clinical trial is to assess the effectiveness of Cognitive Behavioral Play Therapy interventions in patients with epilepsy.Read full original descriptionShow less

The Effects of Cognitive Behavioral Play Intervention on the Quality of Life of Children With Childhood-onset Epileptic Syndromes."

The goal of this clinical trial is to assess the effectiveness of Cognitive Behavioral Play Therapy interventions in patients with epilepsy.

Children with epilepsy will be randomly assigned to one of two intervention conditions: the experimental group will receive cognitive-behavioral play intervention, while the control group will engage in free play. Assessments will be done at the start (T0) and end (T1) of the intervention, measuring behaviors, coping strategies, positive thinking, problem-solving, and quality of life.

Exclusion: Children with epilepsy in comorbidity with cognitive disabilities (the relevant cognitive disabilities must be specified with IQ scores); reduced visual or expressive hearing acuity (visually impaired or deaf) will be excluded.

For the purposes of the study, children aged between 6 and 10 years, of both sexes, will be recruited; inclusion criteria Children diagnosed with the following types of epilepsy will be included: childhood self-limiting focal epilepsy (SeLFE); childhood absence epilepsy (CAE); self-limiting centrotemporal paroxysmal epilepsy (SeLECTS); self-limiting epilepsy with autonomic seizures (SeLEAS); childhood occipital epilepsy (COVE); photosensitive occipital lobe epilepsy (POLE).

ClinicalTrials.gov NCT06813612